Medical management of early fetal demise using sublingual misoprostol
- PMID: 12013170
- DOI: 10.1111/j.1471-0528.2002.01075.x
Medical management of early fetal demise using sublingual misoprostol
Abstract
The aim of this study was to determine the efficacy of mifepristone in combination with sublingual misoprostol for the medical management of early fetal demise. Fifty-six consecutive women were studied prospectively. The mean (SD) gestation at diagnosis was 9.6 weeks (1.84). Four women had complete miscarriage with mifepristone alone. The overall success rate was 83.9% and the median induction-miscarriage interval was 8.19 hours (range 0.83 to 37.50 hours). Of those women who had a successful outcome, 91.5% were satisfied with the regimen. Sublingual misoprostol in combination with mifepristone is an effective and safe alternative to vaginal or oral misoprostol in the management of early fetal demise.
Similar articles
-
A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.BJOG. 2005 Aug;112(8):1102-8. doi: 10.1111/j.1471-0528.2005.00638.x. BJOG. 2005. PMID: 16045525 Clinical Trial.
-
A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation.Contraception. 2003 Nov;68(5):335-8. doi: 10.1016/j.contraception.2003.07.004. Contraception. 2003. PMID: 14636936 Clinical Trial.
-
Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.BJOG. 2010 Sep;117(10):1186-96. doi: 10.1111/j.1471-0528.2010.02636.x. Epub 2010 Jun 18. BJOG. 2010. PMID: 20560941 Clinical Trial.
-
A systematic review of the effectiveness, safety, and acceptability of medical management of intrauterine fetal death at 14-28 weeks of gestation.Int J Gynaecol Obstet. 2019 Dec;147(3):301-312. doi: 10.1002/ijgo.12964. Epub 2019 Sep 25. Int J Gynaecol Obstet. 2019. PMID: 31493314
-
Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.Contraception. 2013 Sep;88(3):341-9. doi: 10.1016/j.contraception.2013.05.001. Epub 2013 May 9. Contraception. 2013. PMID: 23756114 Review.
Cited by
-
Comparison of Effectiveness and Patient Satisfaction of Vaginal Versus Oral Misoprostol in Treatment of Missed Miscarriage.Open Access Maced J Med Sci. 2019 Mar 26;7(6):955-958. doi: 10.3889/oamjms.2019.192. eCollection 2019 Mar 30. Open Access Maced J Med Sci. 2019. PMID: 30976339 Free PMC article.
-
Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise.Indian J Pharmacol. 2011 May;43(3):306-10. doi: 10.4103/0253-7613.81513. Indian J Pharmacol. 2011. PMID: 21713096 Free PMC article.
-
Expectant management of miscarriage in view of NICE Guideline 154.J Pregnancy. 2014;2014:824527. doi: 10.1155/2014/824527. Epub 2014 Apr 27. J Pregnancy. 2014. PMID: 24868466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical